A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities
Clinical trial NCT05850286 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05850286
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-21
- Primary completion
- 2026-04-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.